Publications
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | Second Faculty of Medicine, First Faculty of Medicine
- Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn's disease2020 | Second Faculty of Medicine
- Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry2018 | Second Faculty of Medicine
- Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: A large patient cohort study2017 | Second Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
- The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective2023 | Second Faculty of Medicine
Loading network view...